Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Current Drug Targets
|
October 11, 2021
miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to Overcome Drug Resistance in Cancer
Bernice Monchusi, Mandeep Kaur
Genes & Cancer
|
June 25, 2020
microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
Bernice Monchusi, Mandeep Kaur
Plos One
|
August 11, 2017
Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy
Bernice Monchusi, Monde Ntwasa
Frontiers in Immunology
|
October 27, 2025
Cancer-derived exosomes: mediators of immune crosstalk and emerging targets for immunotherapy
Ridwan Mahamed, Bernice Monchusi, Clement Penny, et al.
Frontiers in Oncology
|
June 4, 2026
RBBP6 and cancer: from molecular mechanisms to clinical implications
Philemon N Ubanako, Ekene E Nweke, Zanele Nsingwane, et al.
Progress in Molecular Biology and Translational Science
|
September 12, 2024
Advances in CRISPR-Cas systems for blood cancer
Bernice Monchusi, Phumuzile Dube, Mutsa Monica Takundwa, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 19, 2025
Methodology for Assessing Drug Efficacy: Protocol for Single and Combination Drug Screening Using HeLa Cell Cultures
Phumuzile Dube, Bernice Monchusi, Mutsa M Takundwa, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Current Drug Targets
|
October 11, 2021
miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to Overcome Drug Resistance in Cancer
Bernice Monchusi, Mandeep Kaur
Genes & Cancer
|
June 25, 2020
microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
Bernice Monchusi, Mandeep Kaur
Plos One
|
August 11, 2017
Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy
Bernice Monchusi, Monde Ntwasa
Frontiers in Immunology
|
October 27, 2025
Cancer-derived exosomes: mediators of immune crosstalk and emerging targets for immunotherapy
Ridwan Mahamed, Bernice Monchusi, Clement Penny, et al.
Frontiers in Oncology
|
June 4, 2026
RBBP6 and cancer: from molecular mechanisms to clinical implications
Philemon N Ubanako, Ekene E Nweke, Zanele Nsingwane, et al.
Progress in Molecular Biology and Translational Science
|
September 12, 2024
Advances in CRISPR-Cas systems for blood cancer
Bernice Monchusi, Phumuzile Dube, Mutsa Monica Takundwa, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 19, 2025
Methodology for Assessing Drug Efficacy: Protocol for Single and Combination Drug Screening Using HeLa Cell Cultures
Phumuzile Dube, Bernice Monchusi, Mutsa M Takundwa, et al.
Page
of 1